Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Scientific Reports
|
November 9, 2017
A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model
Aaron C Brault, Arban Domi, Erin M McDonald, et al.
Plos One
|
October 7, 2016
DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus
Melanie Thompson, Sonya L Heath, Bentley Sweeton, et al.
The Journal of Biological Chemistry
|
November 6, 2025
A split luciferase system for studying coronavirus M<sup>pro</sup> dimerization in vitro and in living cells
Renee Delgado, Jyoti Vishwakarma, Javier O Sanlley Hernandez, et al.
Scientific Reports
|
January 18, 2018
A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge
Arban Domi, Friederike Feldmann, Rahul Basu, et al.
Journal of Virology
|
February 6, 2015
CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infection
Suefen Kwa, Shanmugalakshmi Sadagopal, Xiaoying Shen, et al.
Journal of Virology
|
October 13, 2017
HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine
Xiaoying Shen, Rahul Basu, Sheetal Sawant, et al.
Open Forum Infectious Diseases
|
March 24, 2016
Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine
Venkateswarlu Chamcha, Sunil Kannanganat, Sailaja Gangadhara, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
August 22, 2024
SARS-CoV-2 M<sup>pro</sup> inhibitor identification using a cellular gain-of-signal assay for high-throughput screening
Renee Delgado, Jyoti Vishwakarma, Seyed Arad Moghadasi, et al.
Nature Microbiology
|
June 5, 2024
mRNA-encoded Cas13 can be used to treat dengue infections in mice
Mausumi Basu, Chiara Zurla, Tabassum T Auroni, et al.
Journal of Medicinal Chemistry
|
September 11, 2025
Azapeptide-Based SARS-CoV-2 Main Protease Inhibitors: Design, Synthesis, Enzyme Inhibition, Structural Determination, and Antiviral Activity
Philipp Flury, Jyoti Vishwakarma, Katharina Sylvester, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Scientific Reports
|
November 9, 2017
A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model
Aaron C Brault, Arban Domi, Erin M McDonald, et al.
Plos One
|
October 7, 2016
DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus
Melanie Thompson, Sonya L Heath, Bentley Sweeton, et al.
The Journal of Biological Chemistry
|
November 6, 2025
A split luciferase system for studying coronavirus M<sup>pro</sup> dimerization in vitro and in living cells
Renee Delgado, Jyoti Vishwakarma, Javier O Sanlley Hernandez, et al.
Scientific Reports
|
January 18, 2018
A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge
Arban Domi, Friederike Feldmann, Rahul Basu, et al.
Journal of Virology
|
February 6, 2015
CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infection
Suefen Kwa, Shanmugalakshmi Sadagopal, Xiaoying Shen, et al.
Journal of Virology
|
October 13, 2017
HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine
Xiaoying Shen, Rahul Basu, Sheetal Sawant, et al.
Open Forum Infectious Diseases
|
March 24, 2016
Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine
Venkateswarlu Chamcha, Sunil Kannanganat, Sailaja Gangadhara, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
August 22, 2024
SARS-CoV-2 M<sup>pro</sup> inhibitor identification using a cellular gain-of-signal assay for high-throughput screening
Renee Delgado, Jyoti Vishwakarma, Seyed Arad Moghadasi, et al.
Nature Microbiology
|
June 5, 2024
mRNA-encoded Cas13 can be used to treat dengue infections in mice
Mausumi Basu, Chiara Zurla, Tabassum T Auroni, et al.
Journal of Medicinal Chemistry
|
September 11, 2025
Azapeptide-Based SARS-CoV-2 Main Protease Inhibitors: Design, Synthesis, Enzyme Inhibition, Structural Determination, and Antiviral Activity
Philipp Flury, Jyoti Vishwakarma, Katharina Sylvester, et al.
Page
of 3